Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis

Both prescription and over-the-counter (OTC) drugs must be manufactured in accordance with standards established by the Food and Drug Administration (FDA). The agency inspects manufacturing facilities before a drug application can be approved. Any manufacturing deficiencies found would need to be corrected before approval.

Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.

Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.

The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.

  • Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
  • Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
  • Use of checkweighers and sorters
  • Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
  • Use of quality control labeling systems

It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.

...Show More ...Show Less


Manufacturing, Packaging & Detailing Industry Research & Market Reports

  • The 2026-2031 World Outlook for Anticonvulsants for Krabbe Disease Treatments

    ... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More

  • The 2026-2031 World Outlook for Counterfeit Drug Detection Devices

    ... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More

  • The 2026-2031 World Outlook for Dermatophytic Onychomycosis Therapeutics

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Dermatophytic Onychomycosis Treatments

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • 2025 Testing Services for Pharmaceutical, Medical Devices, and Personal Care Products Global Market Size & Growth Report with Updated Country Recession Risk Forecasts

    ... Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling ... Read More

  • The 2026-2031 World Outlook for 3D Printed Drugs

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Effervescent Products

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Antidiabetics

    ... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More

  • The 2026-2031 World Outlook for Anti-Epileptic Drugs

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Anti-Infectives

    ... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More

  • The 2026-2031 World Outlook for Anti-Infective Agents

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Antipsychotic Drugs

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments

    ... (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country ... Read More

  • The 2026-2031 World Outlook for Antivenom Serum

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments

    ... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More

  • The 2026-2031 World Outlook for Acute-Treatment Migraine Drugs

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Advanced Therapy Medicinal Products

    ... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More

  • The 2026-2031 World Outlook for Bench-Top Lyophilizers

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Bacteriophage

    ... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More

  • The 2026-2031 World Outlook for Cycloplegic Agents

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Botanical Extracts

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Capsaicin

    ... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More

  • The 2026-2031 World Outlook for Iron Drugs

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Iron Deficiency Anemia Drugs

    ... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More

  • The 2026-2031 World Outlook for Biotechnology-Pharmaceutical Services Outsourcing

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings